Trademarkia Logo

Canada

C$
ZYMBOSI
ABANDONED SECTION 36

on 27 Nov 2024

Last Applicant/ Owned by

Eli Lilly and Company

Lilly Corporate Center Indianapolis, IN 46285

US

Serial Number

1953208 filed on 22nd Mar 2019

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

ZYMBOSI

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, atopic dermatitis, autoimmune dise Read More

Classification Information


Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.


Classification kind code

11

Mark Details


Serial Number

1953208

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 22nd Nov 2023
Advertised
Submitted for opposition 27
on 27th Oct 2023
Approval Notice Sent
Submitted for opposition 26
on 27th Oct 2023
Approved
Submitted for opposition 22
on 12th Apr 2023
Search Recorded
Submitted for opposition 20
on 12th Apr 2023
Examiner's First Report
Submitted for opposition 287
on 9th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 48
on 1st Feb 2022
Agent Changed
Submitted for opposition 31
on 28th Mar 2019
Formalized
Submitted for opposition 1
on 25th Mar 2019
Created
Submitted for opposition 30
on 22nd Mar 2019
Filed